Programming adult stem cells to treat muscular dystrophy and more by mimicking nature
2015-07-22
(Press-News.org) Stem cells hold great potential for addressing a variety of conditions from spinal cord injuries to cancer, but they can be difficult to control. Scientists are now reporting in the journal ACS Nano a new way to mimic the body's natural approach to programming these cells. Using this method, they successfully directed adult stem cells to turn specifically into muscle, which could potentially help treat patients with muscular dystrophy.
In the 1990s, scientists first isolated human embryonic stem cells, which can turn into any kind of cell in the body, and the promise of a new way to treat diseases emerged. Since then, scientists have also discovered adult stem cells in a number of organs in the body, including the brain, lungs and skin, that can turn into a limited number of cell types. However, harnessing these special cells to treat disease has been difficult. One of the main obstacles has been figuring out how to control them. Ki-Bum Lee and colleagues wanted to tackle this challenge.
The researchers created an artificial version of a transcription factor -- a protein critical to orchestrating stem-cell differentiation -- using gold nanoparticles. They added small molecules to mimic the structure and function of the natural transcription factor that induces muscle-cell growth. The synthetic proteins, called NanoScript, successfully coaxed stem cells derived from fat tissue to become muscle. The researchers say they can potentially design their NanoScript system to grow other cell types, too.
INFORMATION:
The authors acknowledge funding from the National Institutes of Health, the N.J. Commission on Spinal Cord Research and the Rutgers Busch Biomedical Grant Program.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook END
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-22
A guideline--recommendations on diagnosing and treating a particular disorder--aims to present the best possible treatment for patients. However, when guidelines are compiled their authors often have conflicts of interest, for example as a result of funding or membership in specialist societies that are in close contact with industry. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 445-51), Gisela Schott et al. determine that most guideline authors do declare their conflicts of interest. However, this rarely has consequences ...
2015-07-22
Automakers are looking for ways to improve their fleets' average fuel efficiency, and scientists may have a new way to help them. In a report in the journal ACS Applied Materials & Interfaces, one team reports the development of a material that could convert engine heat that's otherwise wasted into electrical energy to help keep a car running -- and reduce the need for fuels. It could also have applications in aerospace, manufacturing and other sectors.
In 2012, the Obama administration announced fuel-efficiency standards that would require U.S. vehicles to average 54.5 ...
2015-07-22
Lithium-ion batteries remain the technology-of-choice for today's crop of electric cars, but challengers are revving up to try to upset the current order. An article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, takes a look at two of the top contenders vying to erode lithium-ion's dominance.
Alex Scott, a senior editor at C&EN, reports on two developments from companies in England that seem poised to compete in the electric car battery market within the next two to four years. One is a sodium-ion version, produced by ...
2015-07-22
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Experts at The University of Nottingham have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The research, published in the academic journal Advanced Materials, could forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
The ...
2015-07-22
Canada has almost eliminated mother-to-child HIV transmission, known as vertical transmission, in recent years by ensuring that all women have the opportunity to be screened for HIV in pregnancy and that women with the disease receive treatment before giving birth.
In 2014, there was only one recorded transmission of the virus to babies born to women known to be living with HIV.
These findings were presented at the International AIDS Society 2015 conference in Vancouver by researchers from the Canadian Perinatal HIV Surveillance Program (CPHSP), a national group that ...
2015-07-22
SALT LAKE CITY- As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with a genetic mapping technique, genome wide association studies (GWAS), and verified in patient populations from North America and Europe. This was the first study to survey the entire human genome for genetic variation influencing survival, and included a total of 1,635 patients.
Published ...
2015-07-22
A test of the Mobile Bridge® Version 4.0 (MB4.0) over a real river demonstrated its viability for practical use. During the test, the bridge was set up without any foundation work, and a vehicle could easily travel across it. This was achieved safely with very few people and without any problems. The MB4.0 viability test results were presented at a symposium of the Japan Society of Civil Engineers (JSCE) on June 23, 2015, by Dr. Ichiro Ario, Assistant Professor at the Institute of Engineering, Hiroshima University.
Background of developing MB:
Natural disasters include ...
2015-07-22
A new theory says dark matter acts remarkably similar to subatomic particles known to science since the 1930s.
We owe a lot to dark matter - it is the thing keeping galaxies, stars, our solar system, and our bodies intact. Yet no one has been able to observe it, and it has often been regarded as a totally new exotic form of matter, such as a particle moving in extra dimensions of space or its quantum version, super-symmetry.
Now an international group of researchers has proposed a theory that dark matter is very similar to pions, which are responsible for binding atomic ...
2015-07-22
Bethesda, MD (July 22, 2015) -- Newborn children born with a mutation in the Plasmalemma Vesicle Associated Protein (PLVAP) gene develop severe protein losing enteropathy, according to a case study1 published in Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association. Protein losing enteropathy is a condition of the GI tract that results in loss of protein from the body, and often leads to severe abdominal swelling, malnutrition and early death in affected infants
The investigators utilized next-generation ...
2015-07-22
This news release is available in German.
New methods for modifying the genome are currently widely discussed: Using CRISPR/Cas for instance, scientists can remove parts of the genetic code of a gene, thereby knocking it out. Furthermore, there are ways to inhibit translation of a gene into a protein. Both methods have in common that they impede production of a protein and should therefore have comparable consequences for an organism. However, it has been shown that consequences can differ, after a gene is either knocked, out or only blocked. Scientist from the ...
LAST 30 PRESS RELEASES:
[Press-News.org] Programming adult stem cells to treat muscular dystrophy and more by mimicking nature
